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BACKGROUND 
The dramatic and persistent decline in age-adjusted cardiovascular disease (CVD) death rates in all 
segments of the U.S. population represented a considerable public health success in the 20th century. However, 
this progress may now be threatened by rising obesity prevalence and the recent, associated increases in diabetes 
and hypertension. CVD remains the leading cause of U.S. morbidity and mortality and accounted for >800,000 
deaths in 2017 (2). By 2030, over 40% of American adults are expected to have some form of CVD (3) with 
associated costs estimated to exceed $800 billion annually.   
 
OBJECTIVE 
We sought to evaluate the most recent national trends in cardiometabolic disease mortality by age, sex, 
and race from 1999 to 2017. 
 
METHODS 
We determined mortality rates attributed to cardiometabolic diseases  using underlying cause of death 
(UCD) on death certificate data from Centers for Disease Control and Prevention’s Wide-Ranging Online Data 
for Epidemiologic Research (WONDER) multiple cause of death files from January 1, 1999 to December 31, 
2017 (2). Mortality rates for decedents whose UCD was listed as heart disease (I00-I09,I11,I13,I20-I51), stroke 
(I60-I69), diabetes (E10-E14), or essential hypertension and hypertensive renal disease (I10,I12,I15) were age-
adjusted using the 2000 U.S. standard population. Age-adjusted mortality rates (AAMR) were examined overall, 
by sex-race groups, and among adults who died prematurely aged <65 years. AAMR ratios quantifying racial 
disparities were calculated as number of deaths per 100,000 person-years in black individuals for every 1 death 
per 100,000 person-years in white individuals. Statistical trends and AAMR annual rate of change were identified 
using JoinPoint and Linear regression (SPSS v21).   
 
FINDINGS 
Trends in AAMR attributable to cardiometabolic UCD from 1999-2017 identify a consistent inflection 
point in 2010 for deaths due to heart disease, stroke, and diabetes (detailed in the Table, Figure, and Supplemental 
Figure). Specifically, the rate of AAMR decline for heart disease slowed considerably after 2010 ( = -8.3 [95% 
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CI -8.8, -7.8; P<0.01] indicating 8.3 fewer deaths per 100,000 person-years per year before 2010, versus  = -1.3 
[-1.9, -0.8; P<0.01] thereafter ). AAMR declines for stroke ( = -2.3 [-2.5, -2.1]; P<0.01) and diabetes ( = -0.4 [-
0.6, -0.3]; P<0.01) were significant only through 2010, with plateauing therafter. Black individuals consistently 
had higher AAMR compared to whites with the widest observed disparities in hypertension-related deaths. 
Overall, hypertension AAMR increased through 2017, although declines were seen after 2003 in black men and 
women. AAMR for decedents <65 years showed similar patterns. 
 
DISCUSSION 
The previous declines in  heart disease, stroke, and diabetes mortality have slowed or stopped since 2010, 
and overall AAMR from hypertension is actually increasing.   Racial disparities in AAMR from cardiometabolic 
diseases have persisted over the past 2 decades.   Increased competing risks for non-CVD death (e.g. homicide) 
among blacks compared with whites may contribute in part to the racial disparities in observed trends. While 
results derived from cross-sectional death certificate data may be subject to potential miscoding due to ill-defined 
UCD, especially for hypertension and diabetes. However, the underlying trends are consistent across all 
cardiometabolic causes of death and are clearly real and substantial. 
Advances in and implementation of evidence-based medical therapy for CVD are estimated to have 
contributed to approximately 50% of the decline in AAMR due to coronary heart disease from 1980 to 2000.(4) 
However, the increasing prevalence of obesity over the last three decades has likely substantially contributed to 
the increased prevalence of poor cardiovascular health and slowing of CVD mortality declines. The increase in 
lifetime maximum body mass index (BMI) from 1988-2011 is estimated to have accounted for approximately 
186,000 excess deaths in 2011 and reduced life expectancy at age 40 by 0.9 years. (5)  
Premature deaths <65 years old showed similar patterns to overall AAMR. If current trends continue, 1.6 
million premature and eminently avoiadable heart disease deaths are projected to occur in the United States 
between 2017 and 2030, underscoring the urgent need for effective public health interventions throughout the life 
course (6). Evidence-based tobacco control and healthy diet policies to promote healthful food and regulate 
processed food and sugar-sweetened beverages could substantially improve cardiometabolic health and increase 
life expectancy. Without targeted efforts focused on minority groups, sex and racial disparities in cardiometabolic  
mortality rates are likely to persist.    
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Table. Trends in Age-Adjusted Mortality Rates Attributable to Leading Cardiometabolic Underlying 
Causes of Death in the U.S., 1999-2017 
AAMR represents age-adjusted mortality rate per 100,000 person-years, directly standardized to the 2000 U.S. 
Census Population  
*Linear regression of AAMR before and after inflection point identified by JoinPoint analysis of overall heart 
disease, stroke, diabetes, or hypertension trend. P<0.05 for comparison of linear trend after compared to before 
inflection point, for all diseases.  
†P for statistical significance of first and second linear regression around JoinPoint regression-identified inflection 
point, respectively. Regression  coefficient represents change in AAMR or AAMR ratio per year.  
‡Linear regression for AAMR ratio calculated across entire study period (1999-2017). 
  
 1999 2003 2007 2011 2013 2015 2017 First Trend* Second Trend* 
         (95% CI) P†  (95% CI) P† 
Heart disease 1999-2010 2010-2017 
Overall 266.5 236.3 196.1 173.7 169.8 168.5 165.0 -8.3 (-8.8, -7.8) <0.01 -1.8 (-2.5, -1.0) <0.01 
  Black men 407.2 372.1 312.4 266.1 262.8 258.6 257.5 -11.9 (-12.7, -11.1) <0.01 -2.7 (-4.3, -1.1) <0.01 
  White men 327.1 288.2 240.3 216.9 213.1 211.2 208.3 -10.0 (-10.7, -9.2) <0.01 -1.8 (-2.7, -1.0) <0.01 
    AAMR ratio 1.24 1.29 1.30 1.23 1.23 1.22 1.24  = -0.002 (-0.004, 0.000); P = 0.03‡ 
  Black women 283.7 258.5 209.8 176.2 172.1 165.7 161.9 -9.7 (-10.5, -8.9) <0.01 -2.8 (-3.8, -1.9) <0.01 
  White women 212.8 188.5 155.4 136.5 132 132.4 128.4 -6.9 (-7.3, -6.5) <0.01 -1.5 (-2.2, -0.9) <0.01 
    AAMR ratio 1.33 1.37 1.35 1.29 1.30 1.25 1.26  = -0.006 (-0.007, -0.004); P < 0.01‡ 
Stroke 1999-2010 2010-2017 
Overall 61.6 54.6 43.5 37.9 36.2 37.6 37.6 -2.3 (-2.5, -2.1) <0.01 -0.1 (-0.5, 0.2) 0.38 
  Black men 89.6 81.6 68.7 55.3 54.1 55.5 56.1 -3.2 (-3.5, -2.9) <0.01 0.03 (-0.4, 0.4) 0.88 
  White men 60.8 52.9 41.3 36.2 35.0 36.1 36.2 -2.4 (-2.6, -2.1) <0.01 -0.1 (-0.4, 0.2) 0.44 
    AAMR ratio 1.47 1.54 1.66 1.53 1.55 1.54 1.55  = 0.002 (-0.002, 0.006); P = 0.38‡ 
  Black women 76.2 71.1 56.4 47.0 44.7 46.7 47.0 -2.8 (-3.1, -2.4) <0.01 -0.2 (-0.8, 0.4) 0.44 
  White women 58.0 51.3 41.2 36.2 34.2 35.9 35.7 -2.1 (-2.3, -1.9) <0.01 -0.1 (-0.5, 0.2) 0.38 
    AAMR ratio 1.31 1.39 1.37 1.30 1.31 1.30 1.32  = -0.003 (-0.006, -0.001); P = 0.01‡ 
Diabetes 1999-2010 2010-2017 
Overall 25.0 25.5 22.8 21.6 21.2 21.3 21.5 -0.4 (-0.6, -0.3) <0.01 0.02 (-0.1, 0.1) 0.64 
  Black men 49.4 51.2 46.1 44.9 44.0 43.9 45.2 -0.6 (-1.0, -0.2) 0.01 0.04 (-0.3, 0.4) 0.75 
  White men 25.8 27.2 24.8 24.3 23.9 24.5 24.9 -0.3 (-0.5, -0.1) 0.01 0.2 (0.1, 0.3) 0.02 
    AAMR ratio 1.91 1.88 1.86 1.85 1.84 1.79 1.82  = -0.006 (-0.010, -0.003); P < 0.01‡ 
  Black women 49.5 47.9 40.6 35.8 34.3 31.9 31.8 -1.5 (-1.7, -1.2) <0.01 -0.6 (-0.8, -0.4) <0.01 
  White women 20.2 20.1 17.5 16.2 15.7 15.6 15.2 -0.5 (-0.6, -0.4) <0.01 -0.1 (-0.2, -0.01) 0.03 
    AAMR ratio 2.45 2.38 2.32 2.21 2.18 2.04 2.09  =  -0.020 (-0.023, -0.017); P < 0.01‡ 
Hypertension 1999-2003 2003-2017 
Overall 6.2 7.6 7.6 8.1 8.5 8.5 9.0 0.3 (0.3, 0.4) <0.01 0.1 (0.04, 0.1) 0.01 
  Black men 17.3 19.1 17.8 17.4 18.3 17.9 18.5 0.5 (0.1, 0.8) 0.02 -0.1 (-0.2, -0.01) 0.04 
  White men 5.2 6.2 6.5 7.2 7.7 7.9 8.5 0.3 (0.2, 0.3) <0.01 0.1 (0.1, 0.2) <0.01 
    AAMR ratio 3.33 3.08 2.74 2.42 2.38 2.27 2.18  = -0.063 (-0.071, -0.055); P < 0.01‡ 
  Black women 15.0 16.9 15.7 14.9 14.7 14.8 15.0 0.5 (0.3, 0.7) 0.01 -0.2 (-0.3, -0.2) <0.01 
  White women 5.2 6.6 6.6 7.1 7.4 7.3 7.6 0.3 (0.3, 0.4) <0.01 0.1 (0.03, 0.1) <0.01 
    AAMR ratio 2.88 2.56 2.38 2.10 1.99 2.03 1.97  = -0.054 (-0.060, -0.047); P < 0.01‡ 
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Figure. Age-adjusted mortality rates due to heart disease (A), stroke (B), diabetes mellitus (C), and 
hypertension (D) as underlying cause of death per 100,000 from 1999 to 2017 in the United States by sex 
and race.  
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Supplemental Figures  
Supplemental Figure 1. Trends in Age-adjusted premature mortality rates (<65 years) due to heart disease 
(A), stroke (B), diabetes mellitus (C), and hypertension (D) as underlying cause of death per 100,000 from 
1999 to 2017 in the United States by sex and race. 
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